Literature DB >> 26573702

Risk factors for intraoperative allogeneic blood transfusion during craniotomy for brain tumor removal in children.

Olivia Vassal1, François-Pierrick Desgranges1, Sylvain Tosetti1, Stéphanie Burgal1, Frédéric Dailler2, Etienne Javouhey3, Carmine Mottolese4, Dominique Chassard1.   

Abstract

BACKGROUND: Several clinical and surgical factors can influence the occurrence of allogeneic blood transfusion (ABT) during oncologic neurosurgery.
OBJECTIVES: To identify the potential predictive factors of ABT during craniotomy for the removal of brain tumors in children and the potential impact of intraoperative ABT on early postoperative outcome.
METHODS: A retrospective study was performed in all pediatric patients younger than 18 years who underwent craniotomy for brain tumor removal from December 2009 to December 2012 in our institution. Pre-, intra-, and postoperative data were collected from medical and stored electronic anesthesia records. The predictors of intraoperative ABT were determined using multivariate logistic regression.
RESULTS: A total of 110 patients were included. Twenty-seven patients (25%) received intraoperative ABT with a volume of 16 ± 8 ml·kg(-1) . On multivariate analysis, an age <4 years, a duration of surgery >270 min, and a preoperative hemoglobin <12.2 g·dl(-1) were independently associated with the need for intraoperative ABT. We did not show any significant difference concerning postoperative early outcome and length of stay between the transfused and non-transfused patients except for the duration of postoperative mechanical ventilation that was significantly higher in the transfused group (P = 0.04).
CONCLUSION: In children, craniotomy for brain tumor removal is at risk of intraoperative ABT. An age <4 years, a duration of surgery >270 min, and a preoperative hemoglobin <12.2 g·dl(-1) are the main factors associated with intraoperative ABT during this surgery.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  brain tumor; child; intraoperative; logistic regression; outcome; transfusion

Mesh:

Year:  2015        PMID: 26573702     DOI: 10.1111/pan.12810

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  6 in total

1.  Red Blood Cell Transfusions Following Resection of Skull Base Meningiomas: Risk Factors and Clinical Outcomes.

Authors:  Carlito Lagman; John P Sheppard; Joel S Beckett; Alexander M Tucker; Daniel T Nagasawa; Giyarpuram N Prashant; Alyssa Ziman; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2018-05-14

2.  Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Marie E Steiner; Nicole D Zantek; Simon J Stanworth; Robert I Parker; Stacey L Valentine; Leslie E Lehmann; Cassandra D Josephson; Scot T Bateman; Naomi L C Luban
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

3.  Bleeding properties according to surgical sites during pediatric craniotomy: a retrospective study comparing the two stages of epilepsy surgery.

Authors:  Bora Lee; Myung Il Bae; Darhae Eum; Abel Mussa Ntungi; Byongnam Jun; Kyeong Tae Min
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31

4.  Craniotomy Complicated by Severe Metabolic Acidosis Requiring Massive Transfusion in an Infant on Ketogenic Diet Therapy for Intractable Epilepsy.

Authors:  Seth B Hayes; Dolly M Munlemvo; Holly C Gillis; Joseph D Tobias
Journal:  Int Med Case Rep J       Date:  2022-02-15

5.  Pediatric Intracranial Tumors over a 5-Year Period in a Tertiary Care Center of North Kerala, India: A Retrospective Analysis.

Authors:  Aparna Govindan; Rajeev Mandaka Parambil; Jacob Paul Alapatt
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec

6.  Efficacy of Intraoperative Blood Salvage in Cerebral Aneurysm Surgery.

Authors:  Bedjan Behmanesh; Florian Gessler; Elisabeth Adam; Ulrich Strouhal; Sae-Yeon Won; Daniel Dubinski; Volker Seifert; Juergen Konczalla; Christian Senft
Journal:  J Clin Med       Date:  2021-12-07       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.